Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Type
Public
HQ
Thousand Oaks, US
Founded
1980
Size (employees)
17,900 (est)-7%
Amgen was founded in 1980 and is headquartered in Thousand Oaks, US

Key People at Amgen

Robert A. Bradway

Robert A. Bradway

Chairman and Chief Executive Officer
Suzanne Blaug

Suzanne Blaug

SVP, Global Marketing and Commercial Development

Amgen Office Locations

Amgen has offices in Thousand Oaks, Phoenix, Tokyo, Moscow and in 60 other locations
Thousand Oaks, US
Moscow, RU
Dubai, AE
Copenhagen, DK
Vienna, AT
Nashville, US
Shanghai, CN
São Paulo, BR
Beirut, LB
Munich, DE
Saint Paul, US
Zagreb, HR
Boulogne-Billancourt, FR
New Orleans, US
Boise, US
Albany, US
Uxbridge, GB
Burnaby, CA
Phoenix, US
London, GB

Amgen Metrics

Amgen Summary

Market capitalization

$129 B

Closing share price

$174
Amgen's current market capitalization is $129 B.

Amgen Financials

Amgen's revenue is $21.7 B in FY, 2015 which is 7.97% increase from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$21.7 B$20.1 B$18.7 B

Revenue growth, %

8.0%7.4%

Gross profit

$17.4 B$15.6 B$15.3 B

Operating income

$8.47 B$6.19 B$5.87 B

Operating expense total

$8.97 B$9.45 B$9.46 B

Net Income

$6.94 B$5.16 B$5.08 B

Operating cash flow

$413 M$-74 M$548 M

Amgen Market Value History

Market Position – drug development, scientific research, Manufacturing & Industrial, biotech, pharma, clinical research, Health

Amgen Online Presence

Amgen News

Amgen Company Life

You may also be interested in